OneRobotics (06600.HK) recently released its first annual report since listing. In 2025, the company achieved revenue of RMB 900 million (+47.7% YoY) and an adjusted net profit of RMB 12.766 million, crossing the profitability threshold. The core business focuses on AI embodied home robots, which contribute nearly 90% of revenue, almost all of which is generated overseas. To expand the brand and educate the market, sales expenses surged 81.3% to RMB 312 million, significantly outstripping revenue growth. The company recently made a strategic investment of RMB 241 million for a 21% stake in Hitbot, strengthening its R&D in core components like dexterous hands and robotic arms.
Following the two-week ceasefire agreement reached between the U.S. and Iran, Japanese and South Korean stock markets opened sharply higher. Under the deal, the United States and Israel will suspend military operations in exchange for Iran reopening the Strait of Hormuz. South Korea'sKOSPI Composite Indexsurged5.33%to5,787.76
According to the latest data released by the World Semiconductor Trade Statistics (WSTS), global semiconductor sales surged 25.6% year-on-year to$791.7 billionin 2025. The organization projects that the global semiconductor market will maintain robust growth momentum in 2026, with sales expected to climb26.3%year-on-year to reach$975 billion.
BUSY MING (01768.HK), the first volume snack retail stock on the Hong Kong market, released its first annual report showing strong growth. In 2025, the company achieved revenue of RMB 66.17 billion (+68.2%) and net profit of RMB 2.329 billion (+180.9%), with gross margin rising to 9.8%. The total store count reached 21,948 (99.9% franchised), with 7,813 new franchised stores opened in 2025 at an average of 21.4 per day. As the market enters the "3.0 era," competition has shifted toward profitability quality. Institutions warn that same-store sales are under downward pressure, and the payback period has lengthened from 1–2 years to 2–3 years.
Singapore's ETF market surpassed S$18bn in AUM, with S$2.4bn net inflows in 2025 and 69% ADT growth. It covers local equities, gold, bonds, REITs, plus AI and fintech themes. NewTimeSpace Research views its “local+global” structure as a transparent window for cross-border allocation.
Youibot refiled its Hong Kong IPO application on March 31, 2026, aiming to become the "first mobile manipulation robot stock." By 2024 revenue, it ranked first in the global industrial mobile manipulation robot market. Shareholders include SoftBank Ventures Asia and IDG Capital.
The first annual report of AUX Electric (02580.HK) since its listing reflects significant operational challenges. Although revenue exceeded RMB 30 billion (+0.97%) in 2025, net profit attributable to the parent company fell sharply by 23.2% to RMB 2.235 billion. Profitability is under pressure, with the net profit margin sliding from 10% in 2023 to 7.44%. Hit by soaring costs for raw materials like copper (+34.3%) and refrigerants, its core "low-price strategy" has seen margins squeezed to the limit by cost inflation and technical bottlenecks. As of April 2, 2026, the company’s share price closed at HK$9.53, a cumulative decline of over 45% from the HK$17.42 offer price.
Ab&B Bio-Tech (02627.HK) announced a trading suspension effective April 1, 2026, due to incomplete audit procedures regarding fund investments and consultancy payment verifications. Although the earnings preview estimated 2025 revenue at RMB 446–493 million (up ~72%-90% YoY) with narrowed losses, the share price plunged approximately 58.94% in the 14 trading days prior to suspension due to profit-taking following its inclusion in the Stock Connect. The company is heavily dependent on its core product, the quadrivalent influenza subunit vaccine "Huierkangxin®," which contributes approximately 99% of its total revenue, indicating an extremely concentrated income source.
Recently, large holders known as "whales" in the market have decisively shifted from a long-term accumulation pattern to an aggressive net-selling mode.
CaoCao Inc. (02643.HK) recently released its 2025 annual report, showing total revenue of RMB 20.2 billion (+37.7%) and a narrowed net loss of RMB 614 million, with adjusted profit turning positive in the fourth quarter for the first time. However, these results failed to lift the stock in the secondary market; as of March 31, 2026, it closed at HK$25.60, down nearly 39% from its IPO price. Core operational and structural challenges remain: the company is highly dependent on aggregation platforms for over 85% of its orders, with RMB 8.40 of every RMB 100 in revenue flowing to external platforms, significantly eroding profit margins.
Signs of easing tensions emerge between the U.S. and Iran. On April 1, gains expanded across Japanese and South Korean equities, with the KOSPI surging over 6%. SK Hynix jumped nearly 9%, Samsung Electronics advanced more than 8%, and Hyundai Motor climbed over 7%.
NewTimeSpace News: Hang Seng Indexes Company and the Korea Exchange (KRX) jointly launched the "Hang Seng KRX Hong Kong-Korea Index Series" on March 31, 2026, marking their inaugural collaboration. The initial batch comprises four cross-market indices, designed to deepen the connectivity between the Hong Kong and South Korean capital markets.
Distinct Healthcare (02677.HK) recently disclosed its 2025 financial results, with revenue reaching RMB 1.065 billion (+11.1% YoY) and net profit hitting RMB 135 million (+61.2% YoY). Despite reaching a profitability turning point, the stock has continued to slide. As of March 30, 2026, it closed at HK$38.26, a decline of approximately 36.13% from its offer price of HK$59.90. As China’s third-largest private mid-to-high-end integrated medical institution, its market share is only 2.0%. Physical medical services contribute over 92% of revenue, while revenue growth is slowing and remains highly dependent on the Tier-1 markets of Beijing, Shanghai, Guangzhou, and Shenzhen (accounting for >70%).
As the world’s first autonomous driving benchmark with a "US + HK" dual primary listing, Pony AI (02026.HK) closed at HK$74.6 on March 27, 2026, down over 46% from its offer price. Despite 2025 revenue hitting $90 million (+20% YoY) and a significantly narrowed GAAP net loss, the capital market remains cautious about its financial health. The company’s adjusted non-GAAP net loss expanded to $174 million in 2025, with a net operating cash outflow of $165 million, indicating it has yet to close the "self-sustaining" loop.
According to HTX market data, Bitcoin fell below $65,000 this morning, while Ethereum dropped under $1,900. Total cryptocurrency market capitalization now stands at $2.347 trillion, down 2.0% over the past 24 hours.
On March 27, 2026, innovative drug and rare metals sectors led the Shanghai-Shenzhen Stock Connect ETF market. The E Fund Innovative Drug ETF (516080.SH) rose 5.39%, while rare metals and biopharma sectors were also active. The Yinhua 5G Communication ETF (159994.SZ) fell 1.34%, with power and banking sectors experiencing modest pullbacks. Overall, the market exhibited a pattern of strength in pharmaceuticals and resources, with technology and utilities sectors showing consolidation.
